Global Pharmaceutical Intermediates Market: Overview
Pharmaceutical intermediates are the key chemical ingredients in active pharmaceutical ingredients that are used in making medications for the treatment of diseases. The demand for pharmaceutical intermediates is closely intertwined with growing drug making activities across the globe. The evolution of the market is hence underpinned by the various evolution trajectories of the pharmaceutical industry world over. The demand has witnessed rapid boom from the rising demand for drugs for a range of lifestyle medications, especially in developing and developed regions. Broad types of pharmaceutical intermediates comprise chiral building blocks and achiral building blocks.
Report Overview @
Over the years, the adoption of good manufacturing practice (GMP) regulated-drug making activities by pharmaceutical companies has led to the rapid evolution of the pharmaceutical intermediates market. Furthermore, patent expiration of drugs, especially for chronic diseases, in recent years has led to a staggering rise in demand for active pharmaceutical ingredients, world over. This, is turn, has contributed to the rapid strides of the pharmaceutical intermediates market.
The research evaluates the impact of key trends and recent developments on the evolution trajectories of the market. The insights can serve as a useful guide for new entrants and stakeholders access new investment pockets in the pharmaceutical intermediates market.
Request Brochure @
Global Pharmaceutical Intermediates Market: Trends and Opportunities
The rising prevalence of chronic and lifestyle-driven diseases is propelling the demand for active pharmaceutical ingredients, thus driving the pharmaceutical intermediates market. The growing incidence of neurological and cardiovascular diseases, especially among developing and developed regions, is a crucial factor boosting the market. Relentless search for novel drug formulations for several life-threatening diseases is a key trend fueling the expansion of the pharmaceutical intermediates market. The trend gains from strength from the rising investment by prominent drug making companies in research and development activities, notably through contract manufacturing services. The rising demand for pharmaceutical intermediates for new antibiotics and therapeutic drugs is a key trend accentuating the market.
The growth of the global pharmaceutical intermediates market is also bolstered by the rising demand for generic drugs, especially among patient populations in emerging economies. The dynamics may be considerably impacted by the growing number of stringent regulations for the production of active pharmaceutical ingredients. The advent of quality control systems for the production of pharmaceutical intermediates in order the diverse needs of pharmaceutical products is a promising trend catalyzing the market growth. Furthermore, rising number of promising avenues in the pharmaceutical industries, coupled with growing number of contract manufacturing organizations, will help expand the horizon of the pharmaceutical intermediates market.
Request Discount @
Global Pharmaceutical Intermediates Market: Regional Outlook
The study evaluates promising avenues and investment pockets in key regions in the pharmaceutical intermediates market. On the regional front, developed regions notably North America is expected to contribute generous revenues to the overall market, attributed to rising spend on drug making activities by numerous globally prominent pharmaceutical companies. Rapid improvements made in the medical infrastructure has generated large lucrative prospects in emerging regions, especially in Asia Pacific and Latin America. A large chunk of revenue in the pharmaceutical intermediates market is expected to come from countries such as Japan, India, and China.
Global Pharmaceutical Intermediates Market: Competitive Landscape
Prominent companies in the global pharmaceutical intermediates market are entering into collaboration and focusing on mergers and acquisitions, in order to consolidate their presence in the market. Several companies are also exploring new streams of revenue in emerging economies, to gain a better foothold over the competitive dynamics. Some of the key players likely to play prominent role in the evolution of the global pharmaceutical intermediates market are Vertellus Holdings LLC, Sanofi Winthrop Industries S.A., Dishman Group, Life Sciences Private Limited, BASF SE, and Aceto Corporation.